by rscherer | Aug 21, 2017 | News
ROCKVILLE, Md. & SHANGHAI–(BUSINESS WIRE)–20/20 GeneSystems, Inc. (www.2020gene.com) (“20/20”) released this week in China what is believed to be the world’s first machine learning algorithm commercialized for use in conjunction with blood tests to aid...
by rscherer | Dec 27, 2016 | News
Lung cancer efforts: Fighting Barry Foundation, Genesys Biolabs, Paula’s Test
by rscherer | Jan 15, 2016 | News
Investment to Accelerate Commercialization of Lung Cancer Test in China The funds will support 20/20’s efforts to customize for the Chinese market its proprietary algorithm for blood biomarker testing for cancer. The algorithm will then be made available to...
by rscherer | Jul 9, 2015 | News
CHICAGO, July 8, 2015 /PRNewswire/ –Â 20/20 GeneSystems, Inc. (“20/20”) has partnered with Zacks Investment Banking (ZacksIB) and AmeriTech Advisors to raise $4 million in growth capital to support a nationwide roll-out of its proprietary early lung...
by rscherer | Feb 27, 2015 | News
The Montgomery County Department of Economic Development (MCDED) has announced the recipients of the 2015 Life Sciences Impact Grant Awards. The program, introduced in December 2014, was created to provide financial assistance to life sciences employers to retain jobs...
